This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Eisai Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

27.7%

Wachstumsrate der Gewinne

27.5%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum27.6%
Wachstumsrate der Einnahmen9.7%
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

Good

Zuletzt aktualisiertn/a

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Gewinn- und Umsatzwachstumsprognosen

OTCPK:ESAL.Y - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (JPY Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
3/31/2025866,98078,69077,512104,82412
3/31/2024783,39653,07462,26695,41713
3/31/2023744,42057,35963,939104,29313
9/30/2022752,50032,233-8,91330,329N/A
6/30/2022741,59432,69094,326135,806N/A
3/31/2022756,22647,95477,123117,590N/A
12/31/2021712,93557,31185,128124,927N/A
9/30/2021691,25062,50880,215123,618N/A
6/30/2021679,25359,8558,58949,533N/A
3/31/2021645,94242,11935,70973,853N/A
12/31/2020707,88893,68252,35295,670N/A
9/30/2020713,400120,57177,080112,990N/A
6/30/2020707,203124,52381,101116,904N/A
3/31/2020695,621121,76752,556102,782N/A
12/31/2019661,64696,65921,66572,461N/A
9/30/2019631,97457,72512,27362,240N/A
6/30/2019643,53172,74738,72587,299N/A
3/31/2019642,83463,38676,092103,714N/A
12/31/2018627,36763,714151,104171,330N/A
9/30/2018625,10665,679167,298186,973N/A
6/30/2018611,49954,347145,007165,689N/A
3/31/2018600,05451,845124,916149,649N/A
12/31/2017569,81429,04842,23372,041N/A
9/30/2017554,27630,26933,53761,644N/A
6/30/2017544,02729,42549,93176,929N/A
3/31/2017539,09739,35855,85075,851N/A
12/31/2016530,69655,03162,55876,725N/A
9/30/2016542,31371,81266,61278,627N/A
6/30/2016545,60269,227N/A69,710N/A
3/31/2016547,92254,933N/A95,617N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ESAL.Y's forecast earnings growth (27.7% per year) is above the savings rate (2%).

Ertrag vs. Markt: ESAL.Y's earnings (27.7% per year) are forecast to grow faster than the US market (14% per year).

Hohe Wachstumserträge: ESAL.Y's earnings are expected to grow significantly over the next 3 years.

Einnahmen vs. Markt: ESAL.Y's revenue (9.7% per year) is forecast to grow faster than the US market (7% per year).

Hohe Wachstumseinnahmen: ESAL.Y's revenue (9.7% per year) is forecast to grow slower than 20% per year.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Insufficient data to determine if ESAL.Y's Return on Equity is forecast to be high in 3 years time


Wachstumsunternehmen entdecken